急性缺氧不改变肿瘤对FLASH放疗的敏感性
研究在小鼠皮下移植胶质母细胞瘤、头颈癌和肺腺癌模型,通过血管夹闭或卡波金呼吸调控氧供,比较单次20 Gy常规剂量率(CONV)与FLASH放疗。结果显示FLASH在急性缺氧下仍保留抗肿瘤疗效,而CONV不保留;曲美替尼抑制糖酵解可增强FLASH疗效。
要点
- 在多种皮下肿瘤模型中,FLASH在急性缺氧条件下仍保持抗肿瘤疗效,而CONV不保持。
- RNAseq分析显示人胶质母细胞瘤中FLASH特异性表达谱涉及细胞周期阻滞、核糖体生物合成减少及氧化磷酸化向糖酵解转换。
- 曲美替尼抑制糖酵解在正常和夹闭条件下均增强FLASH疗效。
核心结论
- FLASH在急性缺氧的放射抵抗背景下仍有效,显示出相对于CONV的额外获益。
研究设计与样本
- 在小鼠皮下移植胶质母细胞瘤、头颈癌和肺腺癌等多种肿瘤类型,通过血管夹闭或卡波金呼吸调控氧供。
- 以单次20 Gy剂量在CONV或FLASH下照射肿瘤,测量氧张力、监测肿瘤生长,并取样进行bulk RNAseq和哌莫硝唑分析。
- 在胶质母细胞瘤中用曲美替尼抑制糖酵解以增强FLASH疗效。
主要发现
- 在多种皮下肿瘤模型中,与CONV不同,FLASH在急性缺氧下仍保留抗肿瘤疗效。
- RNAseq分析揭示人胶质母细胞瘤中FLASH特异性表达谱,涉及细胞周期阻滞、核糖体生物合成减少及氧化磷酸化向糖酵解转换。
- 曲美替尼抑制糖酵解在正常和夹闭条件下均增强FLASH疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Tumor hypoxia is a major cause of treatment resistance, especially to radiation therapy at conventional dose rate (CONV), and we wanted to assess whether hypoxia does alter tumor sensitivity to FLASH. METHODS AND MATERIALS: We engrafted several tumor types (glioblastoma [GBM], head and neck cancer, and lung adenocarcinoma) subcutaneously in mice to provide a reliable and rigorous way to modulate oxygen supply via vascular clamping or carbogen breathing. We irradiated tumors using a single 20-Gy fraction at either CONV or FLASH, measured oxygen tension, monitored tumor growth, and sampled tumors for bulk RNAseq and pimonidazole analysis. Next, we inhibited glycolysis with trametinib in GBM tumors to enhance FLASH efficacy. RESULTS: Using various subcutaneous tumor models, and in contrast to CONV, FLASH retained antitumor efficacy under acute hypoxia. These findings show that in addition to normal tissue sparing, FLASH could overcome hypoxia-mediated tumor resistance. Follow-up molecular analysis using RNAseq profiling uncovered a FLASH-specific profile in human GBM that involved cell-cycle arrest, decreased ribosomal biogenesis, and a switch from oxidative phosphorylation to glycolysis. Glycolysis inhibition by trametinib enhanced FLASH efficacy in both normal and clamped conditions. CONCLUSIONS: These data provide new and specific insights showing the efficacy of FLASH in a radiation-resistant context, proving an additional benefit of FLASH over CONV.
引用
- Leavitt RJ, Almeida A, Grilj V, et al. Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy. Int J Radiat Oncol Biol Phys. 2024. PMID: 38387809. doi:10.1016/j.ijrobp.2024.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。